SK283944B6 - Potiahnuté častice na báze granulovaných mikrokryštálov ibuprofénu a spôsob ich prípravy - Google Patents

Potiahnuté častice na báze granulovaných mikrokryštálov ibuprofénu a spôsob ich prípravy Download PDF

Info

Publication number
SK283944B6
SK283944B6 SK566-2001A SK5662001A SK283944B6 SK 283944 B6 SK283944 B6 SK 283944B6 SK 5662001 A SK5662001 A SK 5662001A SK 283944 B6 SK283944 B6 SK 283944B6
Authority
SK
Slovakia
Prior art keywords
ibuprofen
ethylcellulose
respect
particles
coating
Prior art date
Application number
SK566-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK5662001A3 (en
Inventor
Jean-Marc Zuccarelli
Charles Chauveau
Gilles Demichelis
Karine Jean
Original Assignee
Ethypharm S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm S. A. filed Critical Ethypharm S. A.
Publication of SK5662001A3 publication Critical patent/SK5662001A3/sk
Publication of SK283944B6 publication Critical patent/SK283944B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Glanulating (AREA)
SK566-2001A 1998-11-06 1999-11-03 Potiahnuté častice na báze granulovaných mikrokryštálov ibuprofénu a spôsob ich prípravy SK283944B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9814033A FR2785539B1 (fr) 1998-11-06 1998-11-06 Particules enrobees d'ibuprofene cristallin granule
PCT/FR1999/002682 WO2000027368A1 (fr) 1998-11-06 1999-11-03 Particules enrobees d'ibuprofene cristallin granule

Publications (2)

Publication Number Publication Date
SK5662001A3 SK5662001A3 (en) 2001-11-06
SK283944B6 true SK283944B6 (sk) 2004-05-04

Family

ID=9532492

Family Applications (1)

Application Number Title Priority Date Filing Date
SK566-2001A SK283944B6 (sk) 1998-11-06 1999-11-03 Potiahnuté častice na báze granulovaných mikrokryštálov ibuprofénu a spôsob ich prípravy

Country Status (26)

Country Link
US (1) US6951657B1 (de)
EP (1) EP1126829B1 (de)
JP (1) JP3987282B2 (de)
KR (1) KR100586059B1 (de)
CN (1) CN1154482C (de)
AT (1) ATE265206T1 (de)
AU (1) AU765765B2 (de)
BR (1) BR9915111A (de)
CA (1) CA2349503C (de)
CZ (1) CZ292290B6 (de)
DE (1) DE69916876T2 (de)
DK (1) DK1126829T3 (de)
EA (1) EA002897B1 (de)
ES (1) ES2219073T3 (de)
FR (1) FR2785539B1 (de)
HK (1) HK1039890B (de)
HU (1) HU229936B1 (de)
IL (1) IL142787A (de)
MX (1) MXPA01004517A (de)
NZ (1) NZ511479A (de)
PL (1) PL194527B1 (de)
PT (1) PT1126829E (de)
SK (1) SK283944B6 (de)
TR (1) TR200101230T2 (de)
WO (1) WO2000027368A1 (de)
ZA (1) ZA200103630B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795962B1 (fr) 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
FR2824477B1 (fr) * 2001-05-09 2005-09-09 Ethypharm Lab Prod Ethiques Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
EP1800667A1 (de) 2005-12-23 2007-06-27 Losan Pharma GmbH Schnell lösliches Ibuprofen-Granulat
AU2006226293B2 (en) * 2005-03-22 2011-04-07 Losan Pharma Gmbh Solubilized ibuprofen
US8067451B2 (en) * 2006-07-18 2011-11-29 Horizon Pharma Usa, Inc. Methods and medicaments for administration of ibuprofen
EP1919288A4 (de) * 2005-07-18 2009-12-16 Horizon Therapeutics Inc Famotidin- und ibuprofenhaltige arzneimittel und ihre verabreichung
US20080020040A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Unit dose form for administration of ibuprofen
DE102005049001A1 (de) * 2005-10-11 2007-04-12 Basf Ag Verfahren zur Herstellung von direkttablettierbaren Ibuprofen-Formulierungen
US8067033B2 (en) 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
ATE553755T1 (de) * 2006-07-27 2012-05-15 Univ Sunderland Stärke enthaltende beschichtungszusammensetzung
TWI564008B (zh) 2010-09-30 2017-01-01 鹽野義製藥股份有限公司 難溶性藥物之溶解性改善製劑
WO2014198999A1 (en) * 2013-06-13 2014-12-18 Opes Corporation Oy Matrix
US9474699B2 (en) * 2014-03-31 2016-10-25 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of a basic benefit agent
WO2016081783A1 (en) * 2014-11-19 2016-05-26 Kiromic, Llc Novel nanoparticle-based vaccine targeting cancer/testis antigens (cta) and its use in solid and hematological malignancies
WO2019080693A1 (zh) 2017-10-26 2019-05-02 浙江越甲药业有限公司 一种稳定的含有非甾体抗炎药衍生物的药物组合物
AU2020225818A1 (en) 2019-02-22 2021-10-14 Catalent U.K. Swindon Zydis Limited Preserving functionally-coated API particles produced by solventless mixing processes in aqueous suspension
GB2597577B (en) 2019-02-22 2023-09-20 Catalent Uk Swindon Zydis Ltd Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
CN113453662A (zh) * 2019-02-22 2021-09-28 康特伦英国斯温顿捷迪斯有限公司 储存期间药物颗粒包衣材料的团聚最小化以稳定化药物产品的崩解时间

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
US4588612A (en) * 1985-04-24 1986-05-13 Scm Corporation Pretreatment in encapsulation process
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
US4835186A (en) 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
NZ234587A (en) * 1989-08-04 1991-11-26 Mcneil Ppc Inc A chewable pharmaceutical tablet of compressed coated granules
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
CA2076983A1 (en) * 1990-04-11 1991-10-12 Robert Wu-Wei Shen Taste masking of ibuprofen by fluid bed coating
FR2679451B1 (fr) * 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
US5191114A (en) * 1991-10-09 1993-03-02 Sage Pharmaceuticals, Inc. Process for enhancing the flow characteristics of ibuprofen
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)

Also Published As

Publication number Publication date
ZA200103630B (en) 2002-05-06
NZ511479A (en) 2003-02-28
ATE265206T1 (de) 2004-05-15
EP1126829B1 (de) 2004-04-28
AU1050800A (en) 2000-05-29
EA200100491A1 (ru) 2001-12-24
FR2785539B1 (fr) 2004-04-09
KR20010090830A (ko) 2001-10-19
CZ292290B6 (cs) 2003-08-13
CN1328450A (zh) 2001-12-26
CA2349503A1 (fr) 2000-05-18
US6951657B1 (en) 2005-10-04
HK1039890B (zh) 2005-01-07
MXPA01004517A (es) 2003-06-09
PL347549A1 (en) 2002-04-08
SK5662001A3 (en) 2001-11-06
JP3987282B2 (ja) 2007-10-03
KR100586059B1 (ko) 2006-06-07
AU765765B2 (en) 2003-09-25
BR9915111A (pt) 2001-11-27
PL194527B1 (pl) 2007-06-29
HU229936B1 (en) 2015-01-28
JP2002529399A (ja) 2002-09-10
EP1126829A1 (de) 2001-08-29
DK1126829T3 (da) 2004-08-09
HK1039890A1 (en) 2002-05-17
FR2785539A1 (fr) 2000-05-12
HUP0104394A3 (en) 2002-12-28
DE69916876D1 (de) 2004-06-03
TR200101230T2 (tr) 2001-10-22
ES2219073T3 (es) 2004-11-16
WO2000027368A1 (fr) 2000-05-18
DE69916876T2 (de) 2005-03-31
PT1126829E (pt) 2004-08-31
CN1154482C (zh) 2004-06-23
HUP0104394A2 (hu) 2002-03-28
IL142787A (en) 2007-06-03
EA002897B1 (ru) 2002-10-31
CA2349503C (fr) 2010-07-13
CZ20011434A3 (cs) 2001-09-12

Similar Documents

Publication Publication Date Title
SK283944B6 (sk) Potiahnuté častice na báze granulovaných mikrokryštálov ibuprofénu a spôsob ich prípravy
KR100767928B1 (ko) 활성 성분의 맛이 차폐되고 활성 성분이 즉시 방출되는 코팅된 과립의 제조 방법
US4840799A (en) Process for preparing rapidly disintegrating granulates
SK6962002A3 (en) A process for the coating of tablet cores and tablets obtained by this process
JP2003531099A (ja) 改良された水溶解度をもつ医薬製剤
PL173676B1 (pl) Sposób wytwarzania nowego preparatu farmaceutycznego w postaci tabletki musującej i/lub rozpadającej się albo w postaci granulatu szybko rozpuszczalnego
SK284811B6 (sk) Farmaceutická formulácia a spôsob jej výroby
JP2002523443A (ja) オメプラゾール製剤
PL186386B1 (pl) Sposób wytwarzania granulatu zawierającego aktywny przy podawaniu drogą doustną antybiotyk beta-laktamowy oraz sposób wytwarzania szybko rozpadającejsię postaci dawkowania zawierającej aktywny przy podawaniu drogą doustną antybiotyk beta-laktamowy
JP4465152B2 (ja) 味をマスキングした、顆粒及びコーティングされた顆粒剤
RU97111870A (ru) Фармацевтический состав, содержащий ламотригин
SK18142001A3 (sk) Matricová zmes s maskovanou chuťou a spôsob jej výroby
AU2012369903A1 (en) Pharmaceutical formulation having improved stability
JPH0691150A (ja) マスクされた粒状物
WO2003070223A1 (fr) Preparations a liberation lente et methode de production desdites preparations
SK164696A3 (en) Carbamazepine medicament with retarded active substance release
SK287281B6 (sk) Viacdávková farmaceutická kompozícia v tuhej perorálnej forme s riadeným uvoľňovaním a spôsob jej prípravy
JP2006306766A (ja) テオフィリン徐放性微粒子製剤及びその製造方法
JP2008184393A (ja) アクリルコポリマーとの混合粉砕による難水溶性薬物の溶解性改善及び放出制御型粒子の調製
KR100759607B1 (ko) 세푸록심 악세틸 과립 및 이의 제조방법
AU2004233606A1 (en) Pellet formulations of acid-labile antiulcer benzimidazole compounds
KR100839283B1 (ko) 암로디핀 및 그 염을 함유한 필름코팅 제제
KR20090005485A (ko) 세푸록심 악세틸 함유 과립 및 그의 제조방법
WO2001076607A1 (fr) Sirop sous forme de substance seche renfermant des microcapsules de theophylline a liberation prolongee
JP2006117577A (ja) テオフィリン含有徐放性製剤

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20191103